AI Clinical Trial Matching Study in 3,804 Cancer Patients by Massive Bio Massive Bio, a global precision oncology company, has announced the publication of a major prospective study demonstrating the…
AHF Launches Nationwide Billboard Campaigns to Promote HIV Care and STD Testing AIDS Healthcare Foundation (AHF), recognized as the world’s largest HIV/AIDS healthcare organization, has unveiled two major national billboard…
Nexus Donates to Kids’ Chance of America to Empower Children of Injured Workers Nexus has announced a meaningful contribution of $10,000 to Kids’ Chance of America, a national nonprofit organization…
Aptar Digital Health Partners with Enable Injections, Inc. to Advance enFuse® Companion Digital Solution Aptar Digital Health, a global leader in digital healthcare solutions focused on improving patient experiences, has…
Assertio to Be Acquired by Garda Therapeutics in $125.1 Million All-Cash Deal Assertio Holdings, Inc. has announced a definitive agreement to be acquired by Garda Therapeutics in an all-cash transaction…
Latent Raises $80M Series A to Transform the Path from Diagnosis to Treatment Latent, a clinical AI company focused on accelerating access to life-saving medications, has announced the successful close…
Bridge Dental Group Expands California Presence with New Glendora Partnerships Bridge Dental Group has announced a significant step forward in its national growth strategy with the addition of two well-established…
Delcath Systems Secures Key Guideline Recognition for CHEMOSAT in Uveal Melanoma Treatment Delcath Systems, Inc., an interventional oncology company specializing in liver-directed cancer therapies, has announced a significant milestone for…
Community Health Systems Expands Community Impact Through Signature Giving Programs Community Health Systems continues to strengthen its commitment to the communities it serves through two of its most impactful annual…
AHF Calls for Equity-Driven Pandemic Agreement on World Health Day Marking World Health Day on April 7, AIDS Healthcare Foundation (AHF) issued a strong appeal for renewed global solidarity in…
Agenus to Present Phase II Data on Novel BOT+BAL and agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026 Agenus a biotechnology company focused on advancing immuno-oncology therapies, has…
Powering PREVOYANCE® with Advanced Image Signal Processing Capabilities A correction has been issued regarding the original press release published on March 31, 2026. In the second paragraph, the certification previously…